BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Carestream Health, Inc. Mammography Expert Highlights Need for Nationwide Screening Protocol for U.S. Women With Dense Breasts


10/8/2013 12:17:11 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ROCHESTER, N.Y., Oct. 8 — Increased awareness of the importance of mammography screening and new imaging modalities that can help with early detection are vital tools in the continuing battle against breast cancer, notes Anne Richards, Carestream’s Clinical Development Manager for Women’s Healthcare.

Richards said that one of the current challenges in the United States is to develop a nationwide screening protocol for women with dense breasts and to establish insurance guidelines for payment of additional imaging exams for these patients. “The American Cancer Society has identified risk factors that can lead to a higher incidence of breast cancer including a family history of cancer and having the BRCA1 or BRCA2 gene mutation. The ACR also reports that having dense breasts produces a ‘moderately increased risk’ of breast cancer.”

She reports that women with dense breasts created “a grassroots movement” that spurred greater discussion among the medical community of which imaging technologies should be used for screening patients with dense breasts. “We now have advanced technologies such as breast ultrasound, breast MRI and digital breast tomosynthesis that each offer distinctly different advantages for viewing calcifications and detecting cancer,” said Richards. “The medical community needs to work with organizations like the ACS and others to help determine the criteria physicians should use to recommend which modality or modalities should be used for screening or follow up imaging studies for women with dense breasts.”

She said that radiologists also need to be trained in diagnosing cancer using each of these modalities. “Breast ultrasound offers different views of the breast, for example, where digital breast tomosynthesis allows radiologists to view 1 millimeter slices of breast tissue. Each technology has its own merits, but training is required to maximize the confidence and accuracy of radiologists using each imaging system.”

Richards believes that screening mammograms remain an important tool in the detection and treatment of breast cancer. “Screening mammography is essential because about 85% of breast cancers occur in women who have no family history of breast cancer. Their primary risk factor is being a woman,” she said. “The good news is that death rates have been decreasing since 1990, especially in women under 50. These decreases are thought to be the result of treatment advances, earlier detection through screening, and increased awareness. However the bad news is that breast cancer death rates for U.S. women are second only to lung cancer. So there is room for improvement in both the detection and treatment of this disease.”

She also recognized improved screening rates among American women in all ethnic groups. According to a 2010 report by the Centers for Disease Control and Prevention (CDC), more than 70 percent of white and African-American women—and 69.7 percent of Hispanic women— aged 50 to 74 years reported they had a mammogram in the last two years. “These numbers represent significant improvement in mammography screenings especially for non-white American women, which has been a major goal over the past 10 to 20 years.”

For more information about Carestream medical imaging and digital mammography solutions, please visit www.carestream.com.

About Carestream Health

Carestream is a worldwide provider of dental and medical imaging systems and IT solutions; X-ray imaging systems for non-destructive testing; and advanced materials for the precision films and electronics markets—all backed by a global service and support network. For more information about the company’s broad portfolio of products, solutions and services, please contact your Carestream representative or call 888-777-2072, or visit www.carestream.com.

CARESTREAM is a trademark of Carestream Health.

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES